Hein Van den Bos | Amsterdam | Hogan Lovells

Hein Van den Bos

Partner Global Regulatory

Languages

English, Dutch, French, German, Spanish

van den Bos Hein

Hein Van den Bos
van den Bos Hein
  • Overview
  • Experience
  • Credentials
  • Insights and events
quote mark

Mentioned as 'rising superstar'

Who's Who Legal Life Sciences, 2015

Hein van den Bos helps Life Sciences companies with EU regulatory matters. He assists pharmaceutical, biotech and medical devices companies on matters relating to the development, approval and marketing of their products. This includes assistance on life cycle management issues such as regulatory data exclusivity and orphan exclusivity, pharmacovigilance, clinical trials, distribution and advertising and promotion. Hein relishes handling cross-border EU and global regulatory projects, working with colleagues across our global Life Sciences practice.

He also assists on a number of compliance matters, such as financial relations with health care professionals, anti-corruption and sunshine rules. Furthermore, Hein helps companies with pricing and reimbursement matters in the Netherlands as well as with Dutch government investigations and enforcement measures. The emerging legal issue of digital health is another area of interest for Hein.

quote mark

Mentioned as 'rising superstar'

Who's Who Legal Life Sciences, 2015

Representative experience

Hein assists pharmaceutical, biotech and medical devices companies with setting up and implementing compliance programs concerning pharmaceutical advertising, anti-corruption and interaction with healthcare professionals.

Credentials

Education
  • MA, International Relations, University of Groningen, 2004
  • Master of Laws, University of Groningen, 2003
Bar admissions and qualifications
  • Amsterdam
Memberships
  • Dutch Association for Pharmacy and Law

Recognition

Healthcare and Life Sciences (Netherlands), Leading Individuals

Legal 500 EMEA

2019-2020
Healthcare and Life Sciences (Netherlands), Recommended

Legal 500 EMEA

2018-2020